Vesicular Stomatitis Virus-Based Epstein-Barr Virus Vaccines Elicit Strong Protective Immune Responses

Epstein-Barr virus (EBV), the first identified human tumor virus, is etiologically associated with various kinds of malignant and benign diseases, accounting for 265,000 cancer incident cases and 164,000 cancer deaths in 2017. EBV prophylactic vaccine development has been gp350 centered for several...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Xiang-Wei, Zhang, Xiao, Bu, Guo-Long, Xu, Hui-Qin, Kang, Yin-Feng, Sun, Cong, Zhu, Qian-Ying, Ma, Run-Bo, Liu, Zheng, Zeng, Yi-Xin, Zeng, Mu-Sheng, Hu, Zhu-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Vaccines and Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093130/
https://www.ncbi.nlm.nih.gov/pubmed/35404082
http://dx.doi.org/10.1128/jvi.00336-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093130/
https://www.ncbi.nlm.nih.gov/pubmed/35404082
http://dx.doi.org/10.1128/jvi.00336-22

Ejemplares similares